Home » Topics » Regulatory » Patents

Patents
RSS

P&G claims alpha2-adrenoceptor agonists with a wide range of potential applications

Aug. 27, 1998

Novel antiinflammatory/antiallergy agents in the pipeline at Japan Energy

Aug. 27, 1998

Pierre Fabre describes antidepressant compounds with a dual mechanism of action

Aug. 27, 1998

Allelix research into antimigraine compounds proves fruitful

Aug. 26, 1998

Pfizer discovers new treatments for atherosclerosis and related disorders

Aug. 26, 1998

Neuroprotective glutamate receptor antagonists disclosed by Warner-Lambert

Aug. 26, 1998

Dual 5-HT reuptake inhibitors/5-HT1A antagonists with potential as antidepressants

Aug. 26, 1998

British Biotech claims MMP inhibitors for blocking connective tissue degradation

Aug. 26, 1998

TAN-2421-A1: a novel xanthine derivative with immunomodulating activity

Aug. 26, 1998

International team identifies compounds for treating slow-growing tumors

Aug. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Deals and an M&A strengthen end-of-year numbers
BioWorld
Two large deals and an acquisition, totaling about $4.64 billion in all, are helping wrap up what’s turning out to be a strong year. Through the first 11 months...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...